-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Mersana Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2016 to Q3 2024.
- Mersana Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 123M shares, a 1.83% increase year-over-year.
- Mersana Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 116M shares, a 24% increase from 2022.
- Mersana Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 93.7M shares, a 32.7% increase from 2021.
- Mersana Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 70.6M shares, a 14.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)